A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
A phase 2 trial of Avelumab and Sacituzumab govitecan in bladder & urothelial cancer, run by EMD Serono Research & Development Institute, Inc., active and no longer recruiting.
Overview
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) is a phase 2 interventional study registered as NCT05327530 by EMD Serono Research & Development Institute, Inc., with 256 participants enrolled, started 2022-08-17 and due to reach its primary completion in 2025-06-20. Interventions recorded: Avelumab, Sacituzumab Govitecan (SG), M6223, NKTR-255 and JB100. Results have been posted on the registry.
Similar pages
not linked directly; found by shared links- TrialAvelumab Program Rollover Study
Shares Avelumab, Merck KGaA (EMD Serono) and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Shares Avelumab, Sacituzumab govitecan, Bladder & urothelial cancer and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
Shares Sacituzumab govitecan, Bladder & urothelial cancer and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
Shares Sacituzumab govitecan and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Patients With Solid Tumor
Shares Sacituzumab govitecan and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments
Shares Sacituzumab govitecan and the tag pipeline.
- TrialA Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
Shares Sacituzumab govitecan and the tag pipeline.
- TrialIntravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
Shares Bladder & urothelial cancer and the tag pipeline.